New Vaccine May Help Stop Deadly Pancreatic Cancers From Coming Back
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small clinical trial suggests.
Pancreatic cancer is one of the most lethal cancers, with a five-year survival rate of about 13%, according to the American Cancer Society.
Further, up to 80% of cases return after treatment, the National Institutes of Health says.